Kingdon Capital Management L.L.C. Grows Stock Holdings in enVVeno Medical Corporation $NVNO

Kingdon Capital Management L.L.C. grew its position in shares of enVVeno Medical Corporation (NASDAQ:NVNO) by 58.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,359,261 shares of the company’s stock after purchasing an additional 500,000 shares during the period. Kingdon Capital Management L.L.C. owned about 0.07% of enVVeno Medical worth $1,232,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of NVNO. Jane Street Group LLC purchased a new position in shares of enVVeno Medical during the 2nd quarter valued at about $51,000. Creative Planning bought a new position in enVVeno Medical during the second quarter valued at approximately $54,000. CM Management LLC purchased a new position in shares of enVVeno Medical during the third quarter worth approximately $544,000. Geode Capital Management LLC lifted its holdings in shares of enVVeno Medical by 1.1% in the 2nd quarter. Geode Capital Management LLC now owns 199,509 shares of the company’s stock worth $796,000 after acquiring an additional 2,211 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of enVVeno Medical in the 2nd quarter worth approximately $798,000. 34.71% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of enVVeno Medical in a report on Monday, December 29th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce”.

enVVeno Medical Price Performance

Shares of enVVeno Medical stock opened at $10.61 on Monday. enVVeno Medical Corporation has a one year low of $8.67 and a one year high of $196.70. The business’s 50 day simple moving average is $10.92 and its two-hundred day simple moving average is $18.02. The stock has a market capitalization of $7.00 million, a P/E ratio of -0.28 and a beta of 1.12.

enVVeno Medical Profile

enVVeno Medical, Inc is a clinical‐stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long‐term intravenous therapy. Through its proprietary Freedom® platform, the company aims to offer an implantable alternative to traditional peripherally inserted central catheters (PICCs) and external tunneled catheters, addressing complications such as infection risk, dislodgement and patient discomfort.

The company’s lead product candidate, the Freedom PICC System, consists of a low‐profile, subcutaneous port connected to a flexible catheter designed for peripheral insertion.